The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease.
OBJECTIVE
Vascular risk factors may contribute to deterioration of cognitive functions in Alzheimer's disease and vascular (or mixed) dementia. Parkinson's disease (PD) is an age-related disorder and vascular risk factors potentially might be the main co-morbidity responsible for motor and cognitive impairment. However, only a few studies focused on this problem have been published. The aim of the study was to assess the contribution of vascular risk factors and white matter abnormalities in magnetic resonance imaging (MRI) on cognitive impairment in PD patients.


METHODS
Sixty consecutive patients (M: 35, F: 25), mean age 68.36 years (SD: 7.25, range: 51-81) with diagnosis of idiopathic PD underwent a semi-structured questionnaire on demographics and vascular risks factors, neurological, neuropsychological and neuroimaging (MRI) examinations with quantitative assessment according to the scale by Wahlund et al. According to cognitive status they were divided into 3 groups: without cognitive disability (I, n=17), with mild cognitive impairment (II, n=25) and with dementia (III, n=18).


RESULTS
There were no significant differences between groups in terms of the number of vascular risk factors (except for the ischaemic heart disease difference between group I and III) and severity of white matter hyperintensities in MRI studies.


CONCLUSIONS
Vascular risk factors along with white matter vascular abnormalities probably do not contribute to cognitive impairment in patients with PD. This is in concordance with previously published studies.
Sławek
Jarosław
J
Zakład Pielêgniarstwa Neurologiczno-Psychiatrycznego, Akademia Medyczna w Gdańsku, Szpital Specjalistyczny oew. Wojciecha, Al. Jana Pawła II 50, 80-462 Gdańsk. jaroslawek@amg.gda.pl
Wieczorek
Dariusz
D
Derejko
Mirosława
M
Dubaniewicz
Mirosława
M
Brockhuis
Bogna
B
Sitek
Emilia
E
Wilczewska
Lucyna
L
Roszmann
Anna
A
Lass
Piotr
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000473:pathology*; D003072:Cognition Disorders / Q000209:etiology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D009460:Neurologic Examination / Q000379:methods; D010300:Parkinson Disease / Q000150:complications* / Q000473:pathology*; D011044:Poland; D011237:Predictive Value of Tests; D017397:Prefrontal Cortex / Q000473:pathology; D011597:Psychomotor Performance; D012307:Risk Factors; D012720:Severity of Illness Index